Effect of Coenzyme Q10 Administration on Polycystic Ovary Syndrome
NCT ID: NCT06659406
Last Updated: 2024-10-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
30 participants
INTERVENTIONAL
2025-01-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Does Coenzyme Q10 alter oxidative stress, inflammation and hyperandrogenism in women with Polycystic ovary syndrome.
Participants will take Coenzyme Q10 200mg, once daily for a period of 3 months. The participants will be reassessed after 12 weeks by measuring Malondialdehyde MDA, C-reactive protein CRP, Sex hormone binding globulin SHBG.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oxidative Stress in Polycystic Ovary Syndrome
NCT06826625
Effect of Theronomic Ova-All Care on Biomarkers of Ovarian Health in Adult Female With Polycystic Ovarian Syndrome
NCT06963840
Study of the Effect of a Nutritional Supplement on Microbiota, Metabolic Control, Inflammatory Profile, and Quality of Life in Patients With Polycystic Ovary Syndrome.
NCT06551285
Efficacy of Injectable Vitamin D Supplementation in Females With Polycystic Ovary Syndrome
NCT06045351
Effects of Senobi Exercise & Aerobic Exercises in Polycystic Ovarian Syndrome
NCT07328048
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CoQ-10 supplementation
The experimental arm will consist of fertile females diagnosed with polycystic ovary syndrome aged between 18 to 50 years. Patients with diabetes mellitus, thyroid dysfunction, cardiovascular diseases, impairment of hepatic and renal function, autoimmune and Inflammatory disorders will be excluded.
Coenzyme Q10
Coenzyme Q10 will be given once daily, 200mg for the period of 3 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Coenzyme Q10
Coenzyme Q10 will be given once daily, 200mg for the period of 3 months
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Unmarried Patients that presented with symptoms due to PCOS
* All patients should fulfill Rotterdam criteria for PCOS
Exclusion Criteria
* Tubal factor infertility (abnormal hysterosalpingography)
* Diabetes mellitus, thyroid dysfunction, cardiovascular diseases, impairment of hepatic and renal function
* Autoimmune and Inflammatory disorders
* Abnormal serum prolactin level
* Smokers
* Alcoholic beverage use
* Use of anti diabetic, anti-obesity drugs, insulin or vitamin and mineral supplements
18 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
College of Physicians and Surgeons Pakistan
OTHER
University of Faisalabad
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
hira zahid
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sana Akram, MBBS, FCPS
Role: STUDY_DIRECTOR
University of Faisalabad
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Madinah Teaching Hospital
Faisalabad, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Hira Zahid, MBBS, Masters in Physiology
Role: backup
References
Explore related publications, articles, or registry entries linked to this study.
Hu X, Wang W, Su X, Peng H, Tan Z, Li Y, Huang Y. Comparison of nutritional supplements in improving glycolipid metabolism and endocrine function in polycystic ovary syndrome: a systematic review and network meta-analysis. PeerJ. 2023 Nov 13;11:e16410. doi: 10.7717/peerj.16410. eCollection 2023.
Related Links
Access external resources that provide additional context or updates about the study.
Efficacy of coenzyme Q10 supplementation on glucose metabolism, lipid profiles, and biomarkers of inflammation in women with polycystic ovary syndrome
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Tuf/IRB/275/24
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.